Evaluation of 68Ga-PSMA I&amp;T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Thorsten Derlin; Sebastian Schmuck; Christoph Klot; Tobias Ludwig Ross; Hans Wester; Frank Bengel

Meeting ReportOncology, Clinical Diagnosis Track

Evaluation of 68Ga-PSMA I&T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Thorsten Derlin, Sebastian Schmuck, Christoph Klot, Tobias Ludwig Ross, Hans Wester and Frank Bengel

Journal of Nuclear Medicine May 2017, 58 (supplement 1) 710;

Thorsten Derlin

2Department of Nuclear Medicine Hannover Medical School Hannover Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sebastian Schmuck

3Medizinische Hochschule Hannover Hannover Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christoph Klot

4MHH Hannover Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tobias Ludwig Ross

1Hannover Medical School Hannover Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hans Wester

5Technische Universitaet Muenchen Garching Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank Bengel

3Medizinische Hochschule Hannover Hannover Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 58, Issue supplement 1

May 1, 2017

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Evaluation of 68Ga-PSMA I&T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Evaluation of 68Ga-PSMA I&T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Thorsten Derlin, Sebastian Schmuck, Christoph Klot, Tobias Ludwig Ross, Hans Wester, Frank Bengel

Journal of Nuclear Medicine May 2017, 58 (supplement 1) 710;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Evaluation of 68Ga-PSMA I&T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Thorsten Derlin, Sebastian Schmuck, Christoph Klot, Tobias Ludwig Ross, Hans Wester, Frank Bengel

Journal of Nuclear Medicine May 2017, 58 (supplement 1) 710;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology, Clinical Diagnosis Track

Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (⁶⁸Ga-RM2) PET/CT
Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
Cancer-associated fibroblasts enhance tumor ¹⁸F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax

Show more Oncology, Clinical Diagnosis Track

Prostate II: Biochemical Recurrence

Detection of Recurrent Prostate Cancer Using ⁶⁸Ga-RM2 PET/MRI in Patients with Negative Conventional Imaging
Clinical impact of 18F-DCFBC PET/CT in biochemical recurrence prostate cancer patients after treatment with curative intent.
PET/MR further improves detection of ⁶⁸Ga-PSMA imaging for early biochemical recurrence in prostate cancer.

Show more Prostate II: Biochemical Recurrence

Main menu

User menu

Search

Evaluation of 68Ga-PSMA I&T PET/CT in 240 Patients with Biochemical Relapse After Primary Therapy for Prostate Cancer : Intraindividual Comparison between Standard and Delayed Imaging

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology, Clinical Diagnosis Track

Prostate II: Biochemical Recurrence

Similar Articles